SG-001 (Sineugene)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSG-001 (Sineugene)
Drug Alias NameAAV gene therapy (Sineugene)AAV based gene therapy (Sineugene)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesShenji Changhua (Beijing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenji Changhua (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral SclerosisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A